What people say about our doctor?
Latest News on Your Doctor's Blog
2016 Pacific Coast Reproductive Society Tradeshow
It’s National Infertility Awareness Week! Do you have questions? Use #InfertilityChat to join the conversation! Visit Resolve.org
We came across a great article and felt we needed to share. Original article can be found on: InVia Fertility Specialists Blog Disclaimer: Reprogene currently has no affiliation with the clinic. We are simply sharing their article. During in vitro fertilization (IVF) in order for implantation and pregnancy to occur, the embryos must reach a stage of development known as ‘blastocyst’. Reaching the blastocyst stage is an integral part of the development of an embryo. Some embryos will reach the blastocyst stage on day 5 after fertilization. Other embryos develop slowly and will not reach the blastocyst stage until day 6 after fertilization. Because of how highly complex the development to the blastocyst stage is, many embryos might never develop into blastocysts. If an embryo cannot reach the blastocyst stage, implantation and pregnancy cannot occur. But what does it mean if the embryo makes a blastocyst on day 5 versus day 6? Is this significant? Are day 5 blastocysts better than day 6 blastocysts? Embryo Development Review The development of an embryo – shown in these pictures – is a time sensitive journey. Day one after fertilization: an embryo is considered to be one-celled and is at the pronuclear stage, commonly referred […]
We are pleased to announce, Reprogene will be at the 2nd CART Educational Seminar on May 24th! We hope to see you there! http://www.coloart.org/
First we want to thank all the clinics who joined in for our webinar. We hope that have piqued your interest about Embryo Mitochondrial DNA Ratio as a Viability Marker. We are very interested in the mtDNA ratio as a viability marker, which is why we are taking the time to complete the evaluation. If you missed our webinar, please email firstname.lastname@example.org requesting the recorded presentation to be sent to you. Are you wondering what the webinar is all about? Here is a preview: Advancements in technology allow for a quick and accurate assessment of the mitochondrial DNA in embryo biopsies. Data from this assessment may be useful as a viability marker and may help determine the best embryos to transfer for higher pregnancy success rates. Current headlines read: “Mitochondria’s role in female fertility” “Evolutionary defined role of the mitochondrial DNA in fertility, disease and ageing” “Mitochondrial DNA mutations affect male and female fertility and ageing” But where do YOU stand? Not enough data to make a determination? Be part of Reprogene’s Evaluation of Embryo Mitochondrial DNA Ratio!!! What are the benefits of being part of our evaluation? Free educational webinar Free lunch (first 3 clinics to confirm attendance) Preview initial […]